AARDHealthcare
Aardvark Therapeutics Inc (AARD) Insider Trading
In the last 90 days, 1 Aardvark Therapeutics Inc (AARD) insider reported no open-market purchases and 1 sale totaling $394,961. Source: SEC Form 4 filings.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 0
- 90-day purchase value
- $0.00
- Corporate buyers
- 0
- Latest transaction
- Sep 11, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
Common questions
AARD insider trading FAQ
- Are AARD insiders buying or selling?
- Over the last 90 days, AARD insiders were net sellers, reporting $0.00 of open-market purchases and $394,961 of sales.
- When was the last AARD insider purchase?
- No open-market insider purchase of Aardvark Therapeutics Inc stock was reported in the last 90 days.
- Where does AARD insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings that Aardvark Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.
Healthcare
Related tickers with recent insider filings
- UTHR insider tradingUnited Therapeutics Corp69 filings
- TWST insider tradingTwist Bioscience Corp37 filings
- TEM insider tradingTempus AI Inc24 filings
- NTRA insider tradingNatera Inc22 filings
- CORT insider tradingCorcept Therapeutics Inc20 filings
- CSTL insider tradingCastle Biosciences Inc20 filings
- CLOV insider tradingClover Health Investments Corp18 filings
- MEDP insider tradingMedpace Holdings Inc18 filings
